Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-COMPASS: Cerebrolysin for Motor Recovery in Subacute Stroke
NCT01996761Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2011
- Primary completion
- Jan 2014
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cerebrolysin in ischemic stroke, sponsored by Samsung Medical Center. Started Jan 2011; status: completed.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01996761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01996761.